
Gensight Biologics SA
PAR:SIGHT

Wall Street
Price Targets
SIGHT Price Targets Summary
Gensight Biologics SA
According to Wall Street analysts, the average 1-year price target for
SIGHT
is 0.388 EUR
with a low forecast of 0.364 EUR and a high forecast of 0.42 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SIGHT's stock price target?
Price Target
0.388
EUR
According to Wall Street analysts, the average 1-year price target for
SIGHT
is 0.388 EUR
with a low forecast of 0.364 EUR and a high forecast of 0.42 EUR.
What is Gensight Biologics SA's Revenue forecast?
Projected CAGR
54%
The
compound annual growth rate
of Gensight Biologics SA's revenue for the next 3 years is
54%.